These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7455430)

  • 21. An analysis of the blood pressure response to labetalol in hypertensive patients.
    McNeil JJ; Anderson AE; Louis WJ
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():449s-452s. PubMed ID: 7318349
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparison between timolol maleate and alphamethyldopa in longterm treatment of essential hypertension (author's transl)].
    G Ital Cardiol; 1981; 11(12):2110-6. PubMed ID: 7346307
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical effects of labetalol in 21 patients with phaeochromocytoma (author's transl)].
    Yoshinaga K; Arakawa K; Ikeda M; Ebihara T; Oe N
    Horumon To Rinsho; 1981 Apr; 29(4):515-22. PubMed ID: 7296922
    [No Abstract]   [Full Text] [Related]  

  • 24. Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life.
    Van Bortel LM; Breed JG; Joosten J; Kragten JA; Lustermans FA; Mooij JM
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):856-62. PubMed ID: 7687708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertension in general practice: a comparative study of labetalol and metoprolol (+/- prazosin) in general practice.
    Piterman L
    Aust Fam Physician; 1981 Jul; 10(7):579-83. PubMed ID: 7283872
    [No Abstract]   [Full Text] [Related]  

  • 27. [Acute and chronic respiratory effects of an alpha-beta antagonist with antihypertensive action].
    Turco P; Dal Negro R
    Clin Ter; 1980 Jun; 93(6):649-55. PubMed ID: 7428320
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of combined alpha- and beta-receptor blockade on peripheral circulation in essential hypertension.
    Heck I; Trübestein G; Stumpe KO
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():429s-432s. PubMed ID: 7318348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The new Russian preparation proxodolol in the treatment of arterial hypertension].
    Ol'binskaia LI; Morozova TE
    Eksp Klin Farmakol; 1994; 57(3):42-5. PubMed ID: 7914119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Labetalol in resistant hypertension].
    Stern N; Teicher A; Rosenthal T
    Harefuah; 1981 Aug; 101(3-4):54-6. PubMed ID: 7319385
    [No Abstract]   [Full Text] [Related]  

  • 31. Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol.
    Elatrous S; Nouira S; Ouanes Besbes L; Marghli S; Boussarssar M; Sakkouhi M; Abroug F
    Intensive Care Med; 2002 Sep; 28(9):1281-6. PubMed ID: 12209278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Labetalol in inadequately controlled hypertensive patients. A twice-daily oral regimen.
    Douglas-Jones AP
    Practitioner; 1980 Aug; 224(1346):841-4. PubMed ID: 7433403
    [No Abstract]   [Full Text] [Related]  

  • 33. [The exercise test with the bicycle ergometer: significance and limitations in the diagnostic and therapeutic evaluation of systemic arterial hypertension].
    Bettinelli CA; Telò D; Cirelli S; Perini A; Savino S
    Boll Soc Ital Cardiol; 1981; 26(10):1119-27. PubMed ID: 7349130
    [No Abstract]   [Full Text] [Related]  

  • 34. IV. Labetalol in the management of severe hypertension.
    Ee B; Aw TC; Yeo PP; Teoh PC; Chia BL
    Singapore Med J; 1981 Oct; 22(5):295-7. PubMed ID: 7344094
    [No Abstract]   [Full Text] [Related]  

  • 35. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ocular and hemodynamic effect of labetalol in rabbits (author's transl)].
    Kogure H; Murakami K; Abiko Y
    Nippon Ganka Gakkai Zasshi; 1980 Oct; 84(10):1450-2. PubMed ID: 7257961
    [No Abstract]   [Full Text] [Related]  

  • 37. [Long-term therapy with labetalol in medium and high grade arterial hypertension].
    Danti G; Pomari S; Covi G; Pedrolli E; Zannini G; Mattioli M; Lechi A
    Clin Ter; 1980 Apr; 93(2):169-82. PubMed ID: 7449336
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical safety and effectiveness of indorenate in essential hypertension.
    Huape-Arreola S; Herrera-Abarca JE; Ruiz-Vega H; Hong E
    Proc West Pharmacol Soc; 2002; 45():197-8. PubMed ID: 12434580
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma.
    Reach G; Thibonnier M; Chevillard C; Corvol P; Milliez P
    Br Med J; 1980 May; 280(6227):1300-1. PubMed ID: 7388518
    [No Abstract]   [Full Text] [Related]  

  • 40. Undulating blood pressure.
    Noppers IM; Zijlstra JG
    Neth J Med; 2008 May; 66(5):212, 214. PubMed ID: 18490800
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.